Daniel Loeb’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-1,513,500
Closed -$47.7M 32
2015
Q3
$47.7M Sell
1,513,500
-1,210,800
-44% -$59.1M 0.45% 27
2015
Q2
$132M Sell
2,724,300
-100,799
-4% -$4.25M 1.23% 27
2015
Q1
$122M Sell
2,825,099
-209,267
-7% -$7.52M 1.13% 28
2014
Q4
$79.8M Hold
3,034,366
0.72% 34
2014
Q3
$53.9M Hold
3,034,366
0.62% 35
2014
Q2
$72.9M Sell
3,034,366
-104,633
-3% -$2.12M 0.9% 31
2014
Q1
$78.9M Buy
3,138,999
+482,150
+18% +$13.3M 1.16% 35
2013
Q4
$58.6M Buy
2,656,849
+406,614
+18% +$8.22M 1.01% 33
2013
Q3
$49.1M Buy
+2,250,235
New +$51.9M 1.2% 23

Other funds holding PGEN

Daniel Loeb's PGEN Position: Q4 2015 in Review

Daniel Loeb sold out of Precigen (PGEN) in Q4 2015, closing a stake of 1,513,500 shares — an estimated $47.7M sold.

Daniel Loeb first reported a position in PGEN in Q3 2013 and held it in 9 quarters. The position peaked at $132M in Q2 2015. 180 funds tracked by Wall St. Rank hold PGEN as of Q4 2015.

  • Daniel Loeb reported no remaining Precigen position as of Q4 2015 after selling out during the quarter.
  • Daniel Loeb sold 1,513,500 Precigen shares in Q4 2015, an estimated $47.7M.
  • Daniel Loeb first reported a position in Precigen in Q3 2013 and held it in 9 quarters.
  • Daniel Loeb's Precigen position peaked at $132M in Q2 2015.
  • 180 funds tracked by Wall St. Rank held Precigen as of Q4 2015.

Based on Third Point's 13F filing for Q4 2015, filed 12 Feb 2016.